Cervical Cancer: Mortality Rates | Organization of Screening Programs | Participation Rates & Target Populations | Other Characteristics

Organization of Cervical Cancer Screening Programs in 20 ICSN Countries, 2007-2008

Region/Country	Program Type¹	Year Program Began	Detection Methods²	AgeGroups Covered	Recommended Interval for average risk (under 70)
Australia	NS	1991	PC	20-69	2 years
Brazil	N	1985	PC	25-59	3 years
Canada	S		PLC, PC	15-69	Varies by prov.
Denmark	NS	1962	PLC, PC	20-59	3 years
Finland	N	1963	PC	30-59	5 years
France	S	1990	PC	25-69	3 years
Germany	O	1971	PC	20-70+	1 year
Hungary	N	2003	PC	25-59	3 years
Iceland	N	1964	PC	20-69	2-3 years
Italy	NS	1996	PLC, PC, HPV-T	25-69	3 years
Ireland	P	2000	PLC	25-69	3 years (25-44); 5 years (45-60)
Japan	NS	1983	PC	20-70+	2 years
Korea	N	2002	PC	30-70+	2 years
Netherlands	N	1989	PLC, PC	30-69	5 years
New Zealand	N	1990	PLC, PC	20-69	3 years
Norway	N	1995	PC, HPV-T	20-69	3 years
Sweden	NS	1969	PC, HPV-T	25-59	3 years
United Kingdom	N	1987	PLC, PC	25-69	3 years (35-49); 5 years (50-64)
United States	O	1991	PLC, PC, HPV-T	40-70+	3 years
Uruguay	S	1994	PLC, PC	30-69	3 years

1 Program Types:

N (National screening policy with national program implementation)
NS (National screening policy with state/provincial/regional screening program implementation)
S (State/Provincial/Regional screening and program implementation)
P (pilot program)
O (Other)

2 Detection Methods:

PLC (Pap test, liquid-based cytology)
PC (Pap test, liquid-based cytology)
HPV-T (HPV test triage)
HPV-P (HPV test primary screening)

International Cancer Screening Network

Organization of Cervical Cancer Screening Programs in 20 ICSN Countries, 2007-2008